Amundi Royalty Pharma PLC Transaction History

Amundi

$295 Billion
Q3 2025

A detailed history of Amundi transactions in Royalty Pharma PLC stock. As of the latest transaction made, Amundi holds 2,069,985 shares of RPRX stock, worth $81.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,069,985

Previous 2,797,471 26.01%

Holding current value

$81.1 Million

Previous $101 Million 27.54%

% of portfolio

0.02%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$34.9 - $37.91 $25.4 Million - $27.6 Million	-727,486 Reduced 26.01%	2,069,985 $73 Million
Q2 2025 Aug 13, 2025	BUY	$30.85 - $36.14 $48.1 Million - $56.4 Million	1,560,093 Added 126.08%	2,797,471 $101 Million
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $33.9 Million - $44.6 Million	-1,316,620 Reduced 51.55%	1,237,378 $38.5 Million
Q4 2024 Feb 07, 2025	SELL	$24.28 - $28.39 $27.6 Million - $32.3 Million	-1,137,257 Reduced 30.81%	2,553,998 $65.2 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $41.7 Million - $47.6 Million	1,627,093 Added 78.83%	3,691,255 $104 Million

Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $3.79 Million - $4.31 Million	-144,293 Reduced 6.53%	2,064,162 $54.4 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $40.8 Million - $46.5 Million	-1,484,441 Reduced 40.2%	2,208,455 $67.1 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $54.5 Million - $60.8 Million	2,080,841 Added 129.08%	3,692,896 $104 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $6.3 Million - $7.52 Million	239,735 Added 17.47%	1,612,055 $43.8 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $10.1 Million - $12.4 Million	339,635 Added 32.89%	1,372,320 $42.2 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $1.39 Million - $1.67 Million	42,409 Added 4.28%	1,032,685 $37.2 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $6.29 Million - $7.08 Million	160,670 Added 19.37%	990,276 $39.1 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $4.27 Million - $4.78 Million	-106,960 Reduced 11.42%	829,606 $34.6 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $23.9 Million - $28.1 Million	636,589 Added 212.21%	936,566 $40.4 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $3.76 Million - $4.25 Million	100,254 Added 50.2%	299,977 $12.2 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $42 Million - $50.7 Million	-1,193,558 Reduced 85.67%	199,723 $8.03 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $51.9 Million - $60.6 Million	-1,434,984 Reduced 50.74%	1,393,281 $50.4 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $113 Million - $132 Million	2,828,265 New	2,828,265 $116 Million

Others Institutions Holding RPRX

# of Institutions

535

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account